project id: TCGA-LIHC; case submitter id: TCGA-XR-A8TC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 9.0; age at index: 43; days to birth: -15817; ethnicity: hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1968; age at diagnosis: 15817; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1339.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: Not Reported; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 908; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-XR-A8TC-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;